Introduction
============

The levels of protein products must be tightly controlled during development for the normal execution of stage-specific processes. For example, in many organisms, the transition from developing to mature oocyte and then to embryo depends on maternally provided mRNAs and proteins. Some proteins are needed at specific times during oocyte development and maturation, and the synthesis of these proteins must be precisely repressed and activated. Proteins that are needed in oogenesis or meiosis can be harmful for embryogenesis, and their accumulation after fertilization must be prevented. Ubiquitin-mediated proteolysis often serves to degrade oocyte proteins after fertilization. In *Caenorhabditis elegans*, the CUL-3--based ubiquitin ligase regulates the meiosis-to-mitosis transition of fertilized embryos by triggering the degradation of MEI-1 ([@bib3]). MEI-1 is a subunit of a katanin microtubule-severing enzyme essential for the assembly of the meiotic spindle, but its activity has to be eliminated before mitosis to form a robust mitotic spindle that orients properly ([@bib4],[@bib5]; [@bib32]). Interestingly, however, *mei-1* mRNA persists in embryos long after meiosis ([@bib5]). This observation suggests that additional mechanisms could be required to prevent the synthesis of new MEI-1 protein.

Translational control also plays an important role in regulating protein levels during oogenesis and the egg-to-embryo transition (for reviews see [@bib9]; [@bib34]; [@bib38]). For example, *Xenopus laevis* Maskin represses the translation of cyclin until oocyte maturation, and *Drosophila* Cup represses the translation of *oscar* and *nanos* mRNAs so that only those mRNAs that are targeted to the posterior cytoplasm of the egg and embryo are activated for translation. Maskin and Cup act at the level of translational initiation as eIF4E-binding proteins (4E-BPs). eIF4E binds to the 5′ cap of mRNAs and in conjunction with eIF4G mediates the recruitment of the 40S ribosomal subunit ([@bib12]). 4E-BPs compete with eIF4G for binding to eIF4E, thus preventing translation initiation. 4E-BPs also play important roles in a variety of processes such as cell cycle progression, oncogenic transformation, and modulation of neuronal activity ([@bib31]). Although some 4E-BPs generally repress translation, others like Maskin and Cup are targeted to a small number of mRNAs through interactions with RNA-binding proteins ([@bib31]). Here, we report the identification of the first 4E-BP orthologue in *C. elegans*, SPN-2. SPN-2 is required for down-regulation of MEI-1 levels during embryonic mitosis, thereby identifying translational regulation as another mechanism for controlling MEI-1 levels during the egg-to-embryo transition.

Results and discussion
======================

SPN-2 is required for normal spindle orientation in early embryos
-----------------------------------------------------------------

A single allele of the *spn-2* gene (spindle orientation defective) was identified in a screen for maternal-effect lethal mutations that disrupt asymmetric division in the *C. elegans* embryo. Homozygous *spn-2* worms also show oogenesis defects and reduced embryo production. The *spn-2(it149)* allele behaves as a recessive, loss-of-function mutation, and all phenotypes are more severe at higher temperatures ([Tables I](#tbl1){ref-type="table"} and [S1](http://www.jcb.org/cgi/content/full/jcb.200903003/DC1)).

###### 

Mutations in *spn-2* cause defects in nuclear and spindle positioning

  Genotype and conditions                                          P0 spindle transverse[a](#tblfn1){ref-type="table-fn"}   Ectopic cleavage furrows[b](#tblfn2){ref-type="table-fn"}   Mispositioned AB or P1 nuclei[c](#tblfn3){ref-type="table-fn"}   Abnormal AB or P1 spindle position[d](#tblfn4){ref-type="table-fn"}
  ---------------------------------------------------------------- -------------------------------------------------------- ----------------------------------------------------------- ---------------------------------------------------------------- ---------------------------------------------------------------------
  Wild type filmed at 23--24C°                                     0/10 (0%)                                                0/10 (0%)                                                   0/10 (0%)                                                        0/10 (0%)
  *spn-2(it149)* filmed at 23--24°C                                1/23 (4%)                                                14/23 (61%)                                                 13/22 (59%)                                                      10/22 (45%)
  *spn-2(it149)* filmed \> 25°C                                    3/13 (23%)                                               12/12 (100%)                                                11/11 (100%)                                                     7/10 (70%)
  *spn-2(it149)* shifted to 25°C; filmed at 23--24°C               11/31 (35%)                                              24/27 (89%)                                                 13/22 (59%)                                                      10/20 (50%)
  *spn-2(it149);mei-1(RNAi)* shifted to 25°C; filmed at 23--24°C   0/17 (0%)                                                6/19 (32%)                                                  3/20 (15%)                                                       5/20 (25%)
  *F56F3.1(RNAi)* filmed at 23--24°C                               5/19 (26%)                                               12/19 (63%)                                                 11/18 (61%)                                                      12/17 (71%)

Hermaphrodites were raised at 20°C and shifted to 25°C for 1--2 h if indicated. Embryos were scored using DIC microscopy during the first two divisions, but those with a transverse P0 spindle, cytokinesis defects, or osmosensitivity were excluded from the analysis of AB and P1 defects.

The spindle was positioned at a \>45° angle relative to the A-P axis of 0° at either metaphase or anaphase. Of the 20 embryos with this phenotype, 17 failed to center and rotate, but then the spindle became normally aligned by anaphase in 11 of those. The remaining three centered and rotated but the spindle moved to a posterior transverse position during metaphase/anaphase.

More than two ingressing cleavage furrows during and just after cytokinesis.

Nuclei were not centrally positioned after cytokinesis.

The AB spindle aligned within 45° of the A-P axis and/or the P1 spindle was transverse to the A-P axis; in wild type, AB spindles are transverse and P1 spindles are aligned.

Wild-type *C. elegans* embryos undergo a series of asymmetric divisions that exhibit precise spindle orientations. After fertilization, an anterior-posterior (A-P) polarity axis is established in the one-cell embryo by the PAR proteins ([@bib11]). The male and female pronuclei meet in the posterior, and the pronuclear--centrosome complex moves to the center and rotates onto the A-P axis ([Fig. 1 A](#fig1){ref-type="fig"}). Spindle displacement toward the posterior results in unequal cell division. Similar spindle movements are repeated in the smaller posterior daughter cell, P1, but not the anterior AB cell ([Fig. 1 A](#fig1){ref-type="fig"}). In most embryos from *spn-2(it149)* mutant mothers grown at 20°C and analyzed at a temperature of 23--24°C, nuclear and spindle positioning in the one-cell stage appeared normal, but alterations in second division spindle orientations were observed. When shifted to higher temperature just before or during filming, some embryos exhibited a posteriorly positioned spindle that was transverse to the A-P axis of the embryo ([Fig. 1 A](#fig1){ref-type="fig"} and [Table I](#tbl1){ref-type="table"}). Astral microtubules were robust in *spn-2* embryos ([Fig. 1 B](#fig1){ref-type="fig"}); however, metaphase spindles were shorter (9.8 ± 0.2 µm; *n* = 8) than in wild type (13.1 ± 0.9 µm; *n* = 6). Most mutant embryos also exhibited ectopic furrows during cytokinesis, and mispositioned nuclei at the two-cell stage before spindle orientation ([Fig. 1 A](#fig1){ref-type="fig"} and [Table I](#tbl1){ref-type="table"}). For simplicity, embryos from *spn-2* mutant mothers will be referred to hereafter as *spn-2* mutants or embryos. All further analyses were performed using *spn-2(it149*), except for the use of RNAi as evidence for the identity of the *spn-2* gene ([Table I](#tbl1){ref-type="table"}).

![**SPN-2 is required for proper spindle positioning.** (A) DIC images of live mitotic embryos. Arrowheads mark the centrosomes and arrows point to ectopic cleavage furrows. (B) Confocal micrographs of α-tubulin (green) and DAPI (blue) staining of one-cell metaphase embryos; epifluorescence images of embryos expressing GFP::PAR-2 or GFP::PGL-1. Bars, 10 µm.](JCB_200903003_RGB_Fig1){#fig1}

To determine if the *spn-2* spindle positioning phenotypes are caused by polarity defects, we examined the localization of PAR-2 and P granules ([@bib11]). As in the wild type, PAR-2::GFP was restricted to the posterior periphery of single-cell *spn-2* embryos ([Fig. 1 B](#fig1){ref-type="fig"}; 9/10, including two embryos with transverse spindles; PAR-2 was lateral in one embryo). Similarly, PGL-1::GFP, a constitutive component of P granules ([@bib17]), was localized to the posterior half of *spn-2* embryos ([Fig. 1 B](#fig1){ref-type="fig"}; 11/12; one had lateral P granules). Finally, the AB cell divided before P1, as in wild type (*n* = 17). These results suggest that SPN-2 affects spindle positioning downstream of the PAR proteins or in an independent pathway.

MEI-1 ectopically localizes to the mitotic spindle in *spn-2* embryos
---------------------------------------------------------------------

Posteriorly mispositioned spindles, ectopic furrows, and mispositioned nuclei are also observed in mutants defective in MEI-1 degradation ([@bib19]; [@bib27]). This led us to examine *spn-2* embryos for ectopic MEI-1 during mitosis. α-MEI-1 antibodies stained the mitotic spindle in all one- and two-cell *spn-2* embryos (*n* = 65) but not in wild type (*n* = 88; [Fig. 2, A and B](#fig2){ref-type="fig"}; and [Table S2](http://www.jcb.org/cgi/content/full/jcb.200903003/DC1)); MEI-1 staining persisted in *spn-2* embryos to at least the 28-cell stage (*n* = 10; [Fig. 2 A](#fig2){ref-type="fig"}). Depletion of MEI-1 by RNAi in *spn-2* mutants suppressed the spindle positioning defects in one-cell stage embryos, and suppressed the ectopic furrows and mispositioned nuclei in many *spn-2* embryos; two-cell stage spindle positioning defects were also reduced ([Fig. 2 C](#fig2){ref-type="fig"} and [Table I](#tbl1){ref-type="table"}). These results indicate that many of the phenotypes observed in early *spn-2* embryos are caused by ectopic MEI-1 localization.

![**MEI-1 ectopically localizes to mitotic spindles in spn-2 embryos.** (A) Confocal micrographs of α-MEI-1 (green) and DAPI (blue) staining. (B) Quantification of spindle MEI-1 levels in one-cell metaphase embryos. (C) DIC images of one-cell anaphase (left) and two-cell interphase (right) embryos. (D) Confocal micrographs of α-MEL-26 (green) and DAPI (blue) staining. (E) Quantification of MEL-26 levels in one-cell embryos. Error bars represent SEM; asterisks indicate statistical significance (P \< 0.05). Bar, 10 µm.](JCB_200903003_RGB_Fig2){#fig2}

MEL-26 is the substrate-specific adaptor that targets MEI-1 to the CUL-3 complex for degradation after meiosis, and thus reduction of MEL-26 leads to ectopic MEI-1 ([@bib19]; [@bib29],[@bib30]). At the same time, MEL-26 is ubiquitinated by CUL-3, and thus defects in the CUL-3 pathway, including the upstream neddylation pathway, lead to higher levels of MEL-26 in addition to failure of MEI-1 degradation ([@bib22]). We therefore examined MEL-26 by indirect immunofluorescence as a readout for the function of the CUL-3 pathway. MEL-26 levels were normal in *spn-2* embryos, in contrast to what was observed after *cul-3(RNAi)* ([Fig. 2, D and E](#fig2){ref-type="fig"}; and Table S2). Thus, the degradation pathway for MEI-1 does not appear to be perturbed in *spn-2* embryos. In addition, MEI-1 levels in *spn-2; mel-26(RNAi)* were higher than those in *spn-2* or *mel-26(RNAi)* embryos, which is consistent with SPN-2 acting in parallel to the MEL-26 degradation pathway ([Fig. 2 B](#fig2){ref-type="fig"} and Table S2).

SPN-2 is an eIF4E-binding protein
---------------------------------

To address how SPN-2 regulates MEI-1 protein levels, we cloned the *spn-2* gene. Mapping and germ-line transformation placed *spn-2* on the cosmid F56F3 (see Materials and methods). Two lines of evidence indicate that *spn-2* corresponds to predicted gene F56F3.1: (1) RNAi of the F56F3.1 gene phenocopied the *spn-2* mutant ([Table I](#tbl1){ref-type="table"}), and (2) sequencing of DNA from *spn-2(it149)* mutants revealed a nonsense mutation in F56F3.1 ([Fig. 3 A](#fig3){ref-type="fig"}). Basic Local Alignment Search Tool (BLAST) searches ([@bib1]) and alignment by Clustal W ([@bib20]) revealed that the predicted F56F3.1/SPN-2 protein shares limited sequence similarity to two 4E-BPs, human eukaryotic translation initiation factor 4E transporter (4E-T), and *Drosophila* Cup ([Fig. 3 B](#fig3){ref-type="fig"}). 4E-T is required for the nucleocytoplasmic shuttling of eIF4E ([@bib8]) and promotes RNA decay in processing bodies ([@bib10]). Cup prevents precocious translation of *oskar* and *nanos* mRNA ([@bib28]). SPN-2 and Cup both contain clusters of glutamine residues in their C-terminal regions, but otherwise the C termini do not show sequence similarity ([@bib24]).

![***spn-2* encodes an eIF4E-binding protein that localizes to the cytoplasm and P granules.** (A) Diagram of *spn-2* intron/exon structure and the *it149* mutation. White, protein coding sequence; gray, Q-rich domain; black, 3′ UTR. (B) Alignments of the N-terminal region of *C. elegans* SPN-2 with human 4E-T and an internal region of *Drosophila* Cup; these regions are 27% and 37% identical, respectively, to SPN-2 (identities shaded). The eIF4E-binding motif (YxxxxLϕ, where ϕ is a hydrophobic residue) is boxed. (C) 6xHis-tagged SPN-2 or SPN-2N were incubated with GST-eIF4E isoforms; eluates were analyzed by Western blotting with α-6xHis. (D) Western blots of wild-type (N2) and *spn-2* worm extracts probed with α-SPN-2N or α-SPN-2C and reprobed with α-tubulin as a loading control. (E--G) Confocal images of wild type or mutants stained with the indicated antibodies and DAPI (blue). (E) One-cell embryos. (F, top) Two-cell embryos. (F, bottom) Wild-type germ-line syncytium, oocytes, and a meiotic embryo. (G) One-cell embryos. Bars, 10 µm.](JCB_200903003_RGB_Fig3){#fig3}

SPN-2 lacks the consensus eIF4E-binding motif found in several 4E-BPs including 4E-T and Cup; however, binding through noncanonical sites has been observed ([@bib33]; [@bib2]; [@bib25]). Therefore, we performed binding assays with GST-tagged eIF4E isoforms and 6xHis-tagged SPN-2 protein expressed and purified from *Escherichia coli*.*C. elegans* has five eIF4E isoforms ([@bib16]; [@bib18]). 6xHis-SPN-2 copurified with GST--IFE-1, -2, -3, and -5 but not with GST--IFE-4 or GST alone ([Fig. 3 C](#fig3){ref-type="fig"}). A SPN-2 N-terminal fragment containing the region similar to other 4E-BPs was sufficient to bind the same eIF4E isoforms ([Fig. 3 C](#fig3){ref-type="fig"}). The specificity of the eIF4E--SPN-2 interaction was confirmed by quantitative assays using IFE-1 and full-length 6xHis-SPN-2, which showed saturable binding with a K~d~ of 0.033 µM ([Fig. S1](http://www.jcb.org/cgi/content/full/jcb.200903003/DC1)). Thus, we conclude that SPN-2 is a bona fide 4E-BP.

SPN-2 localizes to the cytoplasm and to P granules
--------------------------------------------------

To determine the cellular localization of SPN-2, affinity purified antibodies against the SPN-2 N terminus (SPN-2N) and C terminus (SPN-2C) were generated. Western blot assays of embryo extracts using α-SPN-2N revealed an 84-kD protein in wild type and a 59 kD protein in *spn-2* worms ([Fig. 3 D](#fig3){ref-type="fig"}). The levels of truncated product in *spn-2* worms were greatly reduced compared with wild type, especially at 25°C, which is consistent with the more severe phenotype observed at higher temperatures. The α-SPN-2C antibody also recognized an 84-kD protein in wild-type but not the truncated SPN-2 protein.

In situ immunolocalization using both antibodies gave similar staining patterns in wild type, and staining was absent in *spn-2* mutants when α-SPN-2C was used ([Fig. 3 E](#fig3){ref-type="fig"}), or greatly reduced when α-SPN-2N was used. In embryos, SPN-2 staining was observed in the cytoplasm and on large punctae that were partitioned to the posterior of the one-cell embryo (*n* = 17; [Fig. 3 E](#fig3){ref-type="fig"}), as well as to the germ-line P blastomeres in older embryos (*n* = 91). Double-labeling confirmed that the SPN-2 punctae colocalize with P granules ([Fig. 3 F](#fig3){ref-type="fig"}), ribonucleoprotein particles important for germ-line development that contain several translational regulators ([@bib41]). The localization of SPN-2 on P granules thus supports the model that SPN-2 is a 4E-BP that functions in translational control. Cytoplasmic staining and perinuclear punctae were also observed in the meiotic germ line, but only cytoplasmic staining was seen in late oocytes and meiotic embryos, when P granules are dispersed ([Fig. 3 F](#fig3){ref-type="fig"}).

MEI-1 is synthesized during oogenesis and is essential for meiosis. Thus, the presence of SPN-2 at these stages raised the question of when SPN-2 regulates MEI-1. Quantification showed that MEI-1 levels in oocytes and meiotic embryos were not affected in *spn-2* mutants (Table S2), which suggests that SPN-2 down-regulates MEI-1 after meiosis. To determine if P granule localization of SPN-2 is required for MEI-1 regulation, we examined *pgl-1* mutants. In *pgl-1* germ lines and embryos, SPN-2 failed to localize to P granule--like structures but was still present in the cytoplasm ([Fig. 3 G](#fig3){ref-type="fig"}). However, *pgl-1* embryos did not have ectopic MEI-1 staining (*n* = 11; [Fig. 3 G](#fig3){ref-type="fig"}). Together, these results suggest that the cytoplasmic pool of SPN-2 is sufficient to prevent ectopic MEI-1 expression but that some additional regulation must restrict SPN-2\'s effect to mitosis.

OMA-1 interacts with SPN-2 and the *mei-1* 3′ untranslated region (UTR)
-----------------------------------------------------------------------

The identification of SPN-2 as a 4E-BP suggests it controls MEI-1 expression via translational repression. 4E-BPs do not bind target mRNAs directly; rather, specificity is provided by interacting with RNA-binding proteins ([@bib28]). We investigated whether SPN-2 represses *mei-1* translation via OMA-1 and OMA-2, two known RNA-binding proteins and translational repressors ([@bib15]). OMA-1 and OMA-2 function redundantly in oocyte maturation ([@bib7]). Partial depletion of *oma-1* and *oma-2* by RNAi allows maturation and results in embryos with division defects ([@bib26]). We examined early division in *oma-1(RNAi); oma-2(RNAi)* embryos and observed transverse spindles at first division (7/13; [Fig. 4 A](#fig4){ref-type="fig"}), ectopic cleavage furrows during cytokinesis (5/5), and mispositioned nuclei in AB or P1 cells (4/5). All embryos showed ectopic MEI-1 staining during first mitosis (*n* = 9; [Fig. 4 A](#fig4){ref-type="fig"}), and MEI-1 persisted in later stage embryos (*n* = 24; [Fig. 4 A](#fig4){ref-type="fig"}). In addition, MEL-26 levels were normal (Table S2), as seen in *spn-2*. These results suggest that OMA-1 and OMA-2 could be involved in the same pathway as SPN-2 to regulate MEI-1. As OMA-1 and OMA-2 share a high degree (64%) of identity throughout the entire protein, only OMA-1 was tested in further assays.

![**OMA-1 interacts with SPN-2 and the *mei-1* 3′ UTR.** (A) DIC image of a metaphase embryo with skewed spindle (arrowheads mark the centrosomes), and confocal images of embryos stained for MEI-1 (green) and DAPI (blue). Bar, 10 µm. (B and C) In vitro pull-down assays using the proteins shown; eluates were analyzed by Western blotting (WB) with the indicated antibodies. The asterisk in B indicates a band of aggregated MBP in the MBP input lane. (D) MBP--OMA-1 or MBP was incubated with biotinylated sense or antisense RNA from the *mei-1* 3′ UTR. RNA-bound proteins were analyzed by Western blotting.](JCB_200903003_RGB_Fig4){#fig4}

To determine if OMA-1 and SPN-2 interact, in vitro pull-down assays were performed. Maltose-binding protein (MBP)-tagged OMA-1 copurified with GST--SPN-2 bound to glutathione beads, but MBP alone did not; similarly, 6xHis--SPN-2 copurified with MBP--OMA-1 immobilized on amylose resin ([Fig. 4, B and C](#fig4){ref-type="fig"}). 3′ UTRs are often the target for translational control ([@bib6]; [@bib23]). Thus, to test whether OMA-1 binds directly to *mei-1* mRNA, we performed RNA pull-down assays using biotinylated RNA corresponding to the sense or antisense strand of the *mei-1* 3′ UTR. RNAs were incubated with purified MBP--OMA-1 or MBP, and then bound to streptavidin beads. Western blotting of bound proteins showed that the sense strand of *mei-1* 3′ UTR associated with MBP--OMA-1 but not MBP alone ([Fig. 4 E](#fig4){ref-type="fig"}). These results suggest that OMA-1 recruits SPN-2 to the *mei-1* mRNA.

All of our results are consistent with the model that SPN-2 acts with OMA-1 to translationally repress *mei-1* mRNA and thus down-regulate MEI-1 protein levels during mitosis. The activities of severing enzymes for both microfilaments and microtubules must be tightly regulated for normal cytoskeletal function ([@bib39]; [@bib37]). In *C. elegans*, multiple pathways have been described for MEI-1 regulation during the egg-to-embryo transition. The best characterized is the CUL-3--MEL-26 ubiquitin pathway ([@bib86]). Although SPN-2 could regulate components of this pathway, our data argue that SPN-2 acts in parallel to MEL-26. The anaphase-promoting complex (APC) and the MBK-2 kinase have also been shown to promote MEI-1 degradation after meiosis in a MEL-26--independent pathway ([@bib21]), and MBK-2 can target OMA-1 for degradation in the early embryo ([@bib26]; [@bib35]). However, the depletion of APC and MBK-2 only result in ectopic MEI-1 during the first division. In contrast, MEI-1 persists in later embryos in both *spn-2* and *oma-1(RNAi); oma-2(RNAi)* embryos ([Figs. 2 A](#fig2){ref-type="fig"} and [4 A](#fig4){ref-type="fig"}). Further, the levels of OMA-1::GFP expressed under the control of *oma-1* regulatory sequences were comparable in *spn-2* and wild type (Table S2), which indicates that SPN-2 does not act by controlling OMA-1 levels. Recently, phosphorylation of MEI-1 has also been implicated in regulating MEI-1 activity, but this appears to act independently of MEI-1 protein levels, in contrast to what is observed for SPN-2 ([@bib14]). Thus, we propose that translational repression of *mei-1* mRNA by SPN-2 via its interaction with OMA-1 is yet another mechanism to regulate MEI-1 and prevent the deleterious effects of ectopic MEI-1 during mitosis. Northern blot analysis revealed that wild-type mitotic embryos have high levels of *mei-1* mRNA for at least 3 h after meiosis ([@bib5]), and in situ hybridization supports the persistence of *mei-1* mRNA in embryos (Y. Kohara, personal communication). Thus, translational repression by SPN-2 would prevent the synthesis of new MEI-1 protein from this maternally loaded mRNA.

SPN-2 is predicted to act similarly to the Cup and Maskin 4E-BPs, which mediate repression in conjunction with specific RNA-binding proteins. In this case, OMA-1 would bind the *mei-1* 3′ UTR, and recruit SPN-2, which would then bind to eIF4E and prevent translation initiation. Although OMA-1 levels are greatly reduced by the end of the one-cell stage, roles for OMA-1 and -2 in the first two divisions have been reported ([@bib26]; [@bib13]). After the two-cell stage, repression of MEI-1 could be mediated either by very low levels of OMA-1 and -2, or, alternatively, by other RNA-binding proteins; a precedent for sequential action by different repressors has been described for *nos-2* in *C. elegans* ([@bib15]). Both SPN-2 and OMA-1 are also abundant in oocytes and meiotic embryos, but SPN-2 does not appear to repress *mei-1* expression at these stages. 4E-BPs in other systems are regulated by phosphorylation, and thus one possibility is that SPN-2 activity is regulated by the meiosis-to-mitosis transition ([@bib31]). Alternatively, other proteins may interact with *mei-1* mRNA, SPN-2, or OMA-1 to regulate the timing of repression.

In conclusion, we have identified SPN-2 as a 4E-BP protein in *C. elegans* that was not previously identified through homology searches. Although some 4E-BPs have a general effect on translation, others such as Cup and Maskin regulate a subset of messages. We speculate that SPN-2 likewise has a small number of mRNA targets. Although *spn-2*/deletion animals have defects in the late stages of oogenesis, overall larval and adult development appeared normal (Table S1). Further, embryonic polarity and levels of MEL-26 and OMA-1 were normal in *spn-2* embryos, and *mei-1(RNAi)* suppressed most *spn-2* phenotypes. The future study of SPN-2 mRNA targets and interacting proteins will provide new insights into mechanisms of translational regulation during the egg-to-embryo transition.

Materials and methods
=====================

Strains and genetics
--------------------

*C. elegans* were cultured on MYOB plates ([@bib61]) using standard conditions ([@bib60]). The following strains were used in this study. BC4637: *dpy-17 (e164) sDf130 (s2427) unc-32(e189)III; sDp (III, f)*. BC4638: *dpy-17 (e164) sDf127 (s2428) unc-32(e189)III; sDp (III, f)*. BC4697: *dpy-17 (e164) sDf121 (s2098) unc-32(e189)III; sDp (III, f)*. BW1092a: *pgl-1 (ct131)IV* ([@bib17]). CB4856: wild type, Hawaiian variant. JH1623: *unc-119 (ed3); axIs1182\[pie-1:gfp::par-2 + unc-119(+)\]* ([@bib74]). KK781: *spn-2(it149) unc-36 (e251)/qC1 III*. MT8388: *dpy-17 (e164) mpk-1 (oz140)/dpy-17 (e164) unc-79 (e1068)*. N2: wild type, Bristol variant. RL104: *spn-2(it149) dpy-17(e164)/qC1 III*. SS747: *bnIs1\[pie-1::gfp::pgl-1 + unc-119(+)\]* ([@bib44]). TX189: *unc-119 (ed3) III; teIs\[oma-1::gfp+ unc-119(+)\]* ([@bib84]). BC4637, BC4638, and BC4697 were provided by D. Baillie (Simon Fraser University, Burnaby, British Columbia, Canada); BW1092a and SS747 were provided by S. Strome (University of California, Santa Cruz, Santa Cruz, CA); JH1623 was provided by G. Seydoux (Johns Hopkins University, Baltimore, MD); and the remaining strains were obtained from the *Caenorhabditis* Genetics Center at the University of Minnesota or created in the lab.

Molecular identification of *spn-2*
-----------------------------------

A single allele of *spn-2*,*it149*, was identified in a screen of 10,000 haploid genomes for maternal-effect lethal mutations ([@bib43]). Standard linkage and recombination analysis placed *spn-2* on chromosome III, between *daf-2* and *unc-36*. The maternal effect lethality of *spn-2* was complemented by deletion sDf121 but not sDf130, placing *spn-2* between *dpy-27* and *mab-21* ([@bib47]). Single nucleotide polymorphism (SNP) mapping further defined an ∼100-kb region between *mpk-1* and *mab-21* that contains *spn-2*. For SNP mapping ([@bib55]), *spn-2 (it149) dpy-17/qC1* hermaphrodites (Bristol variant) were mated to CB4856 (Hawaiian variant) males to generate heterozygotes, and the *dpy-17 nonspn-2* recombinants were analyzed for the presence of SNP-F25F2\[1\] and SNP-C28A5\[2\] (<http://www.wormbase.org/>). Of 36 recombinants, 24 recombined between dyp-17 and SNP-F25F2\[1\], and 12 recombined between SNP-F25F2\[1\] and SNP-C28A5\[2\], which suggests that *spn-2* was to the right or very close to SNP-C28A5\[2\]. To identify the *spn-2* gene within this region, DNA from *spn-2(it149)* homozygous adults was used for PCR amplification and sequencing of the predicted coding regions of H38K22.2, R07E5.3, R07E5.10, R07E5.17, C28A5.6, C28A5.3, F56F3.1, F56F3.5, and C07G2.3, which are predicted to be involved in microtubule function or were reported to show sterility or cell division phenotypes after RNA-mediated interference. The F56F3 cosmid (from the *C. elegans* Sequence Consortium) was coinjected ([@bib88]) with a plasmid containing *pY110A7A.20::GFP* (which expresses GFP in cilated neurons; provided by G. Ou and J. Scholey, University of California, Davis, Davis, CA) into *spn-2(it149) dpy-17(e164)/qC1* hermaphrodites. Heritable GFP-positive lines were obtained, and GFP *spn-2* segregants that gave rise to \>20 adult progeny were scored as rescued.

RNAi
----

For *spn-2* and *cul-3* RNAi, antisense and sense RNAs were transcribed in vitro (MEGAscript; Applied Biosystems) from linear DNA templates made by the polymerase chain reaction, using T3 (5′-GAAAGCCTTGTTACGCATGGATGC-3′) and T7 (5′-CGTCATCAACTGGTCTCAAGAC-3′) to amplify partial cDNAs from the RB1 library (R. Barstead, Oklahoma Medical Research Foundation, Oklahoma City, OK). Double-stranded RNAs (dsRNAs) were annealed as described previously ([@bib69]). L4 worms were soaked ([@bib53]) in a 1.5-mg/ml solution of *spn-2* dsRNA for 16--24 h at 20°C, or injected with *cul-3* dsRNA and analyzed 24 h later. RNAi was performed by feeding ([@bib79]) wild-type or *spn-2* L4 larvae on freshly induced plates at 20°C for 24 h, 30 h, and 20 h for *mei-1*, *mel-26*, *oma-1*, and *oma-2*, respectively; the L4440 plasmid was used as a control.

Antibodies and immunolocalization
---------------------------------

Fragments of the *spn-2* gene encoding the N-terminal (1--399 aa, SPN-2N) and C-terminal portions of SPN-2 (542--761 aa, SPN-2C) were amplified from the yk635e3 cDNA (provided by Y. Kohara, National Institute of Genetics, Yata, Mishima, Japan) and cloned into pDEST 17 and pDEST 15 vectors (Gateway; Invitrogen) to generate 6×His-tagged and GST-tagged SPN-2 fusions. Fusion proteins were expressed in bacteria and column purified on Ni^2+^-NTA agarose (QIAGEN) or glutathione Sepharose beads (GE Healthcare) using standard procedures. GST--C-terminal SPN-2 and 6×His--N-terminal SPN-2 were injected into rabbits (Covance). Polyclonal antisera were affinity purified against GST:SPN-2N and GST:SPN-2C cross-linked to glutathione beads (<http://www.flemingtonlab.com/Protocols/AbAffinityPurificationProt.pdf>). Antibodies were eluted with 0.2 M glycine-HCl, pH 2.5, immediately neutralized to 1 M K~2~HPO~4~, and dialyzed against 1:1 PBS/glycerol overnight at 4°C.

Whole-worm extracts from ∼50 gravid adult worms were resolved on 10% SDS-polyacrylamide gels, and subjected to Western blotting using standard procedures ([@bib40]). Blots were incubated with α-SPN-2N (1:300,000 in phosphate buffered saline with Tween 20), α-SPN-2C (1:600,000), and α-tubulin DM1a (1:2,000; Sigma-Aldrich) and visualized using the ECL detection system (GE Healthcare).

For in situ immunolocalization, worms were raised at 20°C and processed immediately. For SPN-2 and P granules, worms were cut in egg buffer on poly-lysine--coated slides, freeze-cracked, and fixed in −20°C methanol ([@bib90]). Slides were preblocked with 30% goat serum for 30 min at room temperature. Primary antibodies used were as follows: rabbit α-SPN-2N (1:3,000), rabbit α-SPN-2C (1:6,000), α-P granules (mAbOIC1D4, 1:2; Developmental Studies Hybridoma Bank, developed by [@bib51]). For MEI-1 and MEL-26, embryo fixation and primary antibody incubations were performed as described for MEI-1 (1:100; [@bib4]) and MEL-26 (1:30; [@bib78]). For α-tubulin, slides were fixed in room temperature methanol for 5 min and incubated with DM1a (1:400; Sigma-Aldrich) for 45 min at room temperature, followed by secondary antibody incubation. FITC goat α-rabbit and rhodamine goat α-mouse antibodies (1:200 in PBS; Jackson ImmunoResearch Laboratories) were used as secondary antibodies after preabsorption with acetone powder made from wild-type worms. DAPI (4, 6-diamidino-2-phenylindole dihydrochloride) was used to label nuclei for determination of cell cycle stages.

Microscopy and quantification of staining intensities
-----------------------------------------------------

For live analysis, embryos were cut from hermaphrodites in 80% egg buffer and mounted on poly-lysine--coated slides as described previously ([@bib43]) to prevent flattening. Embryos were filmed under differential interference contrast (DIC) Nomarski optics using a time-lapse video recorder and charge-coupled device (CCD) camera (Panasonic), or examined by epifluorescence using a 100× UPLan-Fl NA 1.30 oil immersion lens (Olympus) on a photomicroscope (BX60; Olympus) equipped with a 12-bit digital CCD camera (Orca; Hamamatsu) and Openlab software (PerkinElmer). For DIC analysis, worms were raised and filmed at the temperatures listed in [Table I](#tbl1){ref-type="table"}. GFP::PGL-1 worms were raised at 20°C and shifted to 25°C for 1 h, and GFP::PAR-2 worms were raised at 24°C to ensure GFP reporter expression, and then filmed at 23--24°C.

For immunolocalization, z series (1 µm optical sections) through the entire embryo were obtained using a laser scanning confocal microscope (FV1000 Fluoview) equipped with a 60× Plan-Apochromat NA 1.42 oil immersion lens (both from Olympus). All images for a particular antibody were taken with identical settings, with the gain adjusted below saturation, using FV10-ASW software (version 1.5.0.14; Olympus). Images were cropped in Photoshop and assembled in Illustrator (both from Adobe). ImageJ (<http://rsb.info.nih.gov/ij/>) was used to measure the mean pixel intensities of areas as follows. For quantification of MEI-1 and MEL-26, four confocal sections at mid-spindle plane or mid-cell plane were merged using maximum-intensity mode. Spindle MEI-1 levels in one-cell embryos were measured within a box of fixed size (16 µm × 8 µm) around the metaphase spindle as determined by DAPI labeling. Spindle MEI-1 levels in meiotic embryos were measured in a circle of 10-µm diameter. Spindle intensities were corrected by subtracting the cytoplasmic contribution measured from circles/boxes of the same sizes. Cytoplasmic MEI-1 values in oocytes were measured from circles of 5-µm diameter. For MEL-26, measurements were from 15-µm-diameter circles in the one-cell cytoplasm. To quantify OMA-1, *spn-2 (it149) dpy17/qC1; OMA-1::GFP* was created by crossing RL104 and TX189. Cytoplasmic intensities were measured in one-cell metaphase embryos from 15-µm-diameter circles in the anterior and posterior and averaged for each embryo. For all measurements, cytoplasmic intensities were corrected by subtracting the intensity of the slide background measured from circles/boxes of the same sizes.

Binding assays
--------------

To test the interaction between SPN-2 and eIF4E, full-length cDNAs for the five eIF4E isoforms of *C. elegans* were subcloned into pDEST 15. GST-tagged eIF4Es or GST expressed in *E. coli* were bound to glutathione Sepharose beads (GE Healthcare), then incubated with purified 6×His-SPN-2 or 6×His-SPN-2N in binding buffer (30 mM Hepes, pH 7.5, 100 mM KCl, 10% glycerol, 1% Triton X-100, 1 mM MgCl~2~, 1 mM DTT, and protease inhibitor cocktail) at 4°C for 2 h. The beads were washed with binding buffer four times and boiled in SDS sample buffer. Eluates were separated by SDS-PAGE and analyzed by Western blotting with α-6xHis monoclonal antibody (Abcam). To generate a saturation binding curve, increasing concentrations of 6xHis-SPN-2 were added to glutathione beads bound with a fixed concentration of GST--IFE-1, or a fixed concentration of 6xHis-SPN-2 was added to glutathione beads bound with increasing concentrations of GST--IFE-1. The purified 6×His-SPN-2 and GST--IFE-1 were detected by Coomassie blue staining and quantified using Image J.

Binding between GST--SPN-2 and MBP--OMA-1 was performed as described for SPN-2 and eIF4E, except that blots were probed with an α-MBP monoclonal antibody (New England Biolabs, Inc.). MBP--OMA-1 or MBP bound to amylose resin (New England Biolabs, Inc.) were incubated with purified 6×His-SPN-2 in binding buffer (20 mM Tris-HCl, pH 7.5, 200 mM NaCl, 1% Triton X-100, 1 mM EDTA, 10 mM β-mercaptoethanol, and protease inhibitor cocktail). Resin was washed with binding buffer four times and boiled in SDS sample buffer. The eluates were analyzed by Western blotting with α-6xHis.

Biotinylated RNA pull-down assay
--------------------------------

PCR-amplified products containing the T7 promoter served as templates for the in vitro synthesis of biotinylated *mei-1* sense 3′ UTR and antisense 3′ UTR using the AmpliScribe T7-Flash transcription kit (EPICENTRE Biotechnologies). 0.5--1 µg of purified MBP--OMA-1 or MBP was incubated with 1 µg of biotinylated RNA for 30 min at room temperature. RNA--protein complexes were isolated using prewashed streptavidin-conjugated Dynabeads (Dynabeads M-280 streptavidin; Invitrogen). Proteins were eluted with SDS sample buffer and analyze by Western blotting with α-MBP.

Online supplemental material
----------------------------

Fig. S1 shows that the interaction between eIF4E and SPN-2 is saturable by a series of GST pull-down assays. Table S1 shows that mutations in *spn-2* result in embryo lethality and reduced embryo production by quantifying the brood size and hatch rate. Table S2 displays quantification of MEI-1, OMA-1::GFP, and MEL-26 levels in different genotypes. Online supplemental material is available at <http://www.jcb.org/cgi/content/full/jcb.200903003/DC1>.
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